About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...

TwoStep Therapeutics, a biotechnology company developing innovative, first-in-class, multispecific targeted peptide conjugate therapies for solid tumors, will be presenting at the 2025 PEGS Boston ...

Sweeping funding cuts are undermining the innovation that has been a central part of US economic strength for decades ...

Those hoping the Court of Appeals for the Federal Circuit would finally resolve priority in the long-pending dispute between the University ...

“We have demonstrated, for the first time worldwide, that CRISPR-Cas9 can be used to incorporate a desired sequence into ...